Burden of diabetic foot ulcers for medicare and private insurers.
about
Phototherapy for treating foot ulcers in people with diabetesA Narrative Review of Diabetes Intervention Studies to Explore Diabetes Care Opportunities for PharmacistsChallenges in the Treatment of Chronic Wounds.Use of Placental Membranes for the Treatment of Chronic Diabetic Foot UlcersRemote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulcerationLosing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complications.Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims data.Amnion Membrane in Diabetic Foot Wounds: A Meta-analysis.Does your patient need diabetic therapeutic footwear? (Where benefit, evidence, and bureaucracy collide).The effect of topical olive oil on the healing of foot ulcer in patients with type 2 diabetes: a double-blind randomized clinical trial study in Iran.A Diabetic Emergency One Million Feet Long: Disparities and Burdens of Illness among Diabetic Foot Ulcer Cases within Emergency Departments in the United States, 2006-2010Illustration of Cost Saving Implications of Lower Extremity Nerve Decompression to Prevent Recurrence of Diabetic Foot UlcerationTowards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factorRisk factors for foot ulceration in adults with end-stage renal disease on dialysis: study protocol for a prospective observational cohort study.Evaluation of negative-pressure wound therapy for patients with diabetic foot ulcers: systematic review and meta-analysis.Pseudomonas aeruginosa uses T3SS to inhibit diabetic wound healing.Molecular typing, virulence traits and antimicrobial resistance of diabetic foot staphylococciEpidemiology of Diabetic Foot Ulcers and Amputations in Romania: Results of a Cross-Sectional Quality of Life Questionnaire Based Survey.Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers.Localization of human adipose-derived stem cells and their effect in repair of diabetic foot ulcers in ratsAtypical Diabetic Foot Ulcer Keratinocyte Protein Signaling Correlates with Impaired Wound Healing.Temperature- and pH-sensitive wearable materials for monitoring foot ulcers.Polybacterial human disease: the ills of social networking.Wound samples: moving towards a standardised method of collection and analysis.Healing Rates in a Multicenter Assessment of a Sterile, Room Temperature, Acellular Dermal Matrix Versus Conventional Care Wound Management and an Active Comparator in the Treatment of Full-Thickness Diabetic Foot Ulcers.Phototherapy for treating foot ulcers in people with diabetes.A longitudinal study of the diabetic skin and wound microbiome.The Monthly Cycle of Hypoglycemia: An Observational Claims-based Study of Emergency Room Visits, Hospital Admissions, and Costs in a Commercially Insured Population.Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis †.Effect of systemic insulin treatment on diabetic wound healing.Cost-of-illness studies in chronic ulcers: a systematic review.A comparative analysis of skin substitutes used in the management of diabetic foot ulcers.Quality of life in patients with diabetic foot ulcer in Visegrad countries.Temporal dynamics of relative abundances and bacterial succession in chronic wound communities.A prospective evaluation of methylene blue and gentian violet dressing for management of chronic wounds with local infection.In vitro assessment of a novel, hypothermically stored amniotic membrane for use in a chronic wound environment.Digital medicine's march on chronic disease.Use of advanced technologies across the wound care spectrum: prologue.A prospective, multicentre, open-label, single-arm clinical trial for treatment of chronic complex diabetic foot wounds with exposed tendon and/or bone: positive clinical outcomes of viable cryopreserved human placental membrane.Meta-analysis on the treatment of diabetic foot ulcers with autologous stem cells.
P2860
Q24188075-02198B2E-5E90-49C7-B97D-A86A4D428608Q26744229-E3C1F0B5-F525-4578-B28D-E2BDFBC053A9Q26784576-D9F8C263-961E-4469-91DD-6873796DFF9FQ26784581-24D1E56B-05D9-4583-8DC3-09E899194EEEQ28078462-A1918E69-F8D6-4D5F-8509-DAAE50054575Q30235338-4A632748-EA0F-4066-93A2-6628C51F915FQ30830475-8513D788-5160-4127-A85B-A275AFC69037Q33664797-BAB48108-CA18-48FB-A035-984B5E4EEA06Q35429036-50854E48-2A18-4836-B12D-A071F3D537C3Q35595968-0B00BAB6-0EEE-4BCD-B8BD-B9C4BF232377Q35738871-3C528FD2-0EA1-474B-B43F-F2B08FD436E6Q35918393-EC98EC4D-5833-4B4F-AF8E-37A46D7D15D7Q35967028-CF931895-9805-4FF9-9981-DE4D1C2475BAQ36073895-2D958248-D7BC-4574-992B-DC08C5F9687DQ36359325-6D2C7E46-AB0A-43CA-8D9E-B0EE2685B9C3Q36401770-6DC012EA-18B5-4575-AADC-292A0A11B827Q36662239-1AC4B35D-A6E5-475D-94BC-32C0A4D102ACQ36670366-4D00B3C7-BB23-4549-B75E-44C1258B6DFFQ37239300-1510CEBD-554E-4141-AE15-F8FE1B546D79Q37358882-7CE30FF5-5CC9-4506-90EB-28198B6B9B9EQ37389836-3F618929-93A2-49FA-9751-DD29398FD019Q37626472-87EB346C-EC8C-4AC6-8074-D38494F3B2F5Q38220972-E08FC7EC-126B-485F-BDC3-5BF3050E3F04Q38315546-6555AF2D-92A6-4D69-85E0-9C17B0CB5E8DQ38366137-895B23DD-9CBF-4380-B1D7-D47C6260AF7FQ38370059-6AF5CEB9-14F0-4D20-8939-3E0FB413C67EQ38663267-E77862AC-FAC3-4542-837B-446DFA39ECB0Q38798258-E23F58EA-4BD4-4A3B-A0DD-702DDD0742C6Q38800111-D09D1DAF-95FF-4428-88E5-83475411C200Q39000608-D8E878C8-2549-4D2F-B9BE-01AC052952E0Q39221460-E4CB8BFA-FFA7-44BE-8D4B-621EE484306FQ39342610-835A5F66-CE90-4CBD-B55E-3EFBD402CDADQ39475730-2A00A229-7743-49D3-919E-BCD28C073C25Q40179123-C1068DEA-4DAA-4295-BA2F-6E17474AFA11Q40210990-E322E406-D0EE-4CB4-893C-644E1AFA9319Q40266946-D6ED3BD6-E813-4BA0-A5C3-EE008374A723Q40358781-9405695B-5169-4F37-948D-BE0C29FD95B1Q40567776-F2746CC1-6127-4872-BCC6-6780F759E6D9Q40589203-54FC9511-7828-49DC-AF2A-DB7B3734DB89Q42690422-81BED85B-07F2-4AA5-B212-C256BF087CF9
P2860
Burden of diabetic foot ulcers for medicare and private insurers.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Burden of diabetic foot ulcers for medicare and private insurers.
@en
Burden of diabetic foot ulcers for medicare and private insurers.
@nl
type
label
Burden of diabetic foot ulcers for medicare and private insurers.
@en
Burden of diabetic foot ulcers for medicare and private insurers.
@nl
prefLabel
Burden of diabetic foot ulcers for medicare and private insurers.
@en
Burden of diabetic foot ulcers for medicare and private insurers.
@nl
P2093
P356
P1433
P1476
Burden of diabetic foot ulcers for medicare and private insurers.
@en
P2093
Alice Kate G Cummings
Howard G Birnbaum
J Bradford Rice
Michelle Skornicki
Nathan B Parsons
Urvi Desai
P304
P356
10.2337/DC13-2176
P407
P577
2013-11-01T00:00:00Z